Cargando…

Performance of an automated external cardioverter defibrillator for inhospital ventricular malignant arrhythmia

Detalles Bibliográficos
Autores principales:	Timerman, S, Bento, A, Cardoso, LF, Moretti, MA, Sanadi, NE, Ramires, JAF
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2003
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3301510/ http://dx.doi.org/10.1186/cc1954

Ejemplares similares

Improved hemodynamics with a novel chest compression device during treatment of inhospital cardiac arrest
por: Timerman, S, et al.
Publicado: (2003)

Use of automated external defibrillators in a major Latin America airline: 5 years' experience
por: Timerman, S, et al.
Publicado: (2004)

Comparison of exponential truncated biphasic versus damped sine wave monophasic shocks in transthoracic cardioversion of atrial fibrillation
por: Kawabata, VS, et al.
Publicado: (2003)

Brazilian heartsaver program: 'Time is Life' campaign
por: Canesin, MF, et al.
Publicado: (2002)

Primary angioplasty versus streptokinase in elderly patients with acute myocardial infarction
por: Leite, PF, et al.
Publicado: (2001)

Effect of IV amiodarone on CPR haemodynamics and outcome: experimental study in dogs
por: Paiva, EF, et al.
Publicado: (2002)

Evolution of extravascular implantable cardioverter-defibrillator therapy for ventricular arrhythmias
por: Römers, Hans, et al.
Publicado: (2022)

Use of automated external defibrillators in the House of Representatives Brazil, the first in Latin America: a 2-year experience
por: Timerman, S, et al.
Publicado: (2005)

The Automatic External Cardioverter-Defibrillator
por: Martínez-Rubio, Antoni, et al.
Publicado: (2004)

Comparison among bilevel noninvasive mechanical ventilation, continuous positive airway pressure and oxygen in the treatment of cardiogenic acute pulmonary edema
por: Park, M, et al.
Publicado: (2001)

Strategies to Reduce Recurrent Shocks Due to Ventricular Arrhythmias in Patients with an Implanted Cardioverter-Defibrillator
por: Back, Steven H, et al.
Publicado: (2019)

Physical activity is reduced prior to ventricular arrhythmias in patients with a wearable cardioverter defibrillator
por: Burch, Ashley E., et al.
Publicado: (2019)

Impact of Myocardial Bridge on Life‐Threatening Ventricular Arrhythmia in Patients With Implantable Cardioverter Defibrillator
por: Okada, Kozo, et al.
Publicado: (2020)

Ventricular arrhythmias among patients with implantable cardioverter‐defibrillator during the COVID‐19 pandemic
por: Malanchini, G., et al.
Publicado: (2021)

Diffuse myocardial fibrosis associates with incident ventricular arrhythmia in implantable cardioverter defibrillator recipients
por: Olausson, Eric, et al.
Publicado: (2023)

Predictive value of gamma-glutamyltransferase for ventricular arrhythmias and cardiovascular mortality in implantable cardioverter-defibrillator patients
por: Zhou, You, et al.
Publicado: (2019)

Myocardial Scar Characterization and Future Ventricular Arrhythmia in Patients With Ischemic Cardiomyopathy and an Implantable Cardioverter-Defibrillator
por: Noordman, Alwin B. P., et al.
Publicado: (2021)

Sex‐specific differences in outcome and risk stratification of ventricular arrhythmias in implantable cardioverter defibrillator patients
por: van der Lingen, Anne‐Lotte C.J., et al.
Publicado: (2021)

Results from inhospital cardiopulmonary resuscitation records in a medical cardiologic ICU
por: Timerman, S, et al.
Publicado: (2006)

Implantable cardioverter defibrillator as a treatment for massive left ventricular fibroma-induced ventricular arrhythmia in a child
por: Choi, In Su, et al.
Publicado: (2021)

Comorbid Hypertension Reduces the Risk of Ventricular Arrhythmia in Chronic Heart Failure Patients with Implantable Cardioverter-Defibrillators
por: Huang, Hao, et al.
Publicado: (2022)

Ventricular tachycardia as presenting arrhythmia as a determinant of appropriate implantable cardioverter-defibrillator therapy in secondary prevention
por: Noordman, A B P, et al.
Publicado: (2023)

Association left ventricular lead and ventricular arrhythmias after upgrade to cardiac resynchronization therapy in patients with implantable cardioverter defibrillators
por: Kawamura, Mitsuharu, et al.
Publicado: (2019)

Main air pollutants and ventricular arrhythmias in patients with implantable cardioverter-defibrillators: A systematic review and meta-analysis
por: Yang, Hong-Jie, et al.
Publicado: (2017)

Automated Implantable Cardioverter Defibrillator/Pacemaker Lead Fracture
por: Rubero, Jose, et al.
Publicado: (2020)

Genome-Wide Association of Implantable Cardioverter-Defibrillator Activation With Life-Threatening Arrhythmias
por: Murray, Sarah S., et al.
Publicado: (2012)

Benefit of a wearable cardioverter defibrillator for detection and therapy of arrhythmias in patients with myocarditis
por: Tscholl, Verena, et al.
Publicado: (2021)

Successful Treatment of an Infant with Left Ventricular Noncompaction Presenting with Fatal Ventricular Arrhythmia Treated with Cardiac Resynchronization Therapy and an Implantable Cardioverter Defibrillator
por: Kimura, Masato, et al.
Publicado: (2018)

Primary Prevention of Fatal Ventricular Arrhythmias With Implantable Cardioverter-Defibrillator Therapy – An Analysis of Implications Based on MADIT II Criteria
por: Carrim, Zia I, et al.
Publicado: (2006)

An interesting implantable cardioverter defibrillator treatment for lethal ventricular arrhythmias caused by coronary artery spasm: A case report
por: Sun, Jie, et al.
Publicado: (2017)

Risk of subsequent ventricular arrhythmia is higher in primary prevention patients with implantable cardioverter defibrillator than in secondary prevention patients
por: Zhou, You, et al.
Publicado: (2019)

Incidence of Ventricular Arrhythmias and 1‐Year Predictors of Mortality in Patients Treated With Implantable Cardioverter‐Defibrillator Undergoing Generator Replacement
por: Demarchi, Andrea, et al.
Publicado: (2021)

Appropriate Implantable Cardioverter-Defibrillator Therapy in Patients with Ventricular Arrhythmia of Unclear Cause in Secondary Prevention of Sudden Cardiac Death
por: Noordman, Alwin B. P., et al.
Publicado: (2023)

A sustained ventricular tachycardia overlooked by subcutaneous implantable cardioverter-defibrillator but recognized by co-implanted transvenous implantable cardioverter defibrillator
por: Goto, Kentaro, et al.
Publicado: (2020)

Atrial fibrillation mimicking ventricular fibrillation confuses an automated external defibrillator
por: Hulleman, M., et al.
Publicado: (2018)

Effects of COVID‐19 lockdown on arrhythmias in patients with implantable cardioverter‐defibrillators in southern Italy
por: Ducceschi, Valentino, et al.
Publicado: (2022)

Implantable cardioverter-defibrillators /
Publicado: (1994)

Impact of Magnesium L-Lactate on Occurrence of Ventricular Arrhythmias in Patients with Implantable Cardioverter Defibrillators: A Randomized, Placebo-Controlled Trial
por: Baker, William L, et al.
Publicado: (2015)

Oversensing of the wearable cardioverter defibrillator during bipolar ventricular stimulation
por: Manninger, Martin, et al.
Publicado: (2017)

Implantable cardioverter-defibrillator shocks and nonsustained rapid ventricular rhythms
por: Witteveen, H., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_l9kcmapce3692d12b1f8ar77ns